Cordlife loses accreditation with blood banking body, posts $12.4 million first-half loss

Singapore News News

Cordlife loses accreditation with blood banking body, posts $12.4 million first-half loss
Singapore Latest News,Singapore Headlines
  • 📰 The Straits Times
  • ⏱ Reading Time:
  • 68 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 30%
  • Publisher: 63%

Association withdrew company's accreditation for cord-blood activities – collection, processing, storage and distribution..

SINGAPORE - Embattled Cordlife Group said on Aug 15 that the international Association for the Advancement of Blood and Biotherapies has withdrawn the company’s AABB accreditation for cord blood activities – collection, processing, storage and distribution.

AABB has notified Cordlife that the association can accredit it only after MOH permits the company to resume its business, after it has fully resolved all quality issues, and has several months of records available for on-site inspection. On receipt of approval from MOH to resume operations, Cordlife will evaluate the feasibility of seeking AABB accreditation at a suitable time, said the group.at different periods since November 2020. The lapses were uncovered by MOH, which suspended the cord blood bank from collecting or processing new cord blood for six months from November 2023.In a separate filing to the Singapore Exchange, the company posted a net loss of $12.

Loss per share for the six months was 4.82 cents. The group had earnings per share of 0.87 cent in the first half of financial year 2023. In July, Cordlife engaged Shandong Qilu Stemcell Engineering to guide and assist the Singapore team during the rectification period. Cordlife’s group chief executive Ivan Yiu said: “We are also exploring new business opportunities in other markets to mitigate the impact of our Singapore operations.”In a third bourse filing, Cordlife said it intends to reallocate the remaining funds it has from a private placement proposed in 2013 of 26.8 million shares at an issue price of $1.25 per share.Cordlife said about $23.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

The Straits Times /  🏆 8. in SG

Singapore Latest News, Singapore Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Would you pay S$12 for Mao Shan Wang durian kaya toast?Would you pay S$12 for Mao Shan Wang durian kaya toast?Ms Durian cafe has launched three new offerings for National Day, including this luxe spin on a breakfast fave. 8days.sg samples some.
Read more »

Man charged with misappropriating S$12 million from wine investment schemeMan charged with misappropriating S$12 million from wine investment schemeSINGAPORE: A man who was behind a multi-million dollar wine investment scheme was on Thursday (Aug 8) charged for cheating and related offences.
Read more »

Thailand moves closer to legalising casinos to prop up tourismThailand moves closer to legalising casinos to prop up tourismThailand can lift tourism revenue by about US$12 billion by legalising casinos, a study found.
Read more »

Cordlife loses accreditation with international blood bank bodyCordlife loses accreditation with international blood bank bodyCord blood bank Cordlife also recorded a S$12.35 million loss for the first half of the year.
Read more »

Cordlife loses accreditation with international blood bank bodyCordlife loses accreditation with international blood bank bodyThe beleaguered private cord blood bank also recorded a S$12.35 million loss for the first half of the year.
Read more »

Another Cordlife director arrested amid investigations into mishandling of cord blood unitsAnother Cordlife director arrested amid investigations into mishandling of cord blood unitsCordlife said it in the process of identifying additional independent directors to strengthen the capabilities of its board.
Read more »



Render Time: 2025-04-25 12:51:27